AMTX vs. ASPI, LXFR, LNZA, SLI, ARQ, ORGN, TSE, SDST, ALTO, and VGAS
Should you be buying Aemetis stock or one of its competitors? The main competitors of Aemetis include ASP Isotopes (ASPI), Luxfer (LXFR), LanzaTech Global (LNZA), Standard Lithium (SLI), ARQ (ARQ), Origin Materials (ORGN), Trinseo (TSE), Stardust Power (SDST), Alto Ingredients (ALTO), and Verde Clean Fuels (VGAS). These companies are all part of the "chemicals" industry.
Aemetis vs.
Aemetis (NASDAQ:AMTX) and ASP Isotopes (NASDAQ:ASPI) are both small-cap oils/energy companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations.
Aemetis received 172 more outperform votes than ASP Isotopes when rated by MarketBeat users. However, 100.00% of users gave ASP Isotopes an outperform vote while only 59.87% of users gave Aemetis an outperform vote.
In the previous week, ASP Isotopes had 29 more articles in the media than Aemetis. MarketBeat recorded 30 mentions for ASP Isotopes and 1 mentions for Aemetis. ASP Isotopes' average media sentiment score of 0.10 beat Aemetis' score of 0.00 indicating that ASP Isotopes is being referred to more favorably in the news media.
Aemetis has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.48, suggesting that its stock price is 248% more volatile than the S&P 500.
27.0% of Aemetis shares are held by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are held by institutional investors. 15.9% of Aemetis shares are held by insiders. Comparatively, 21.4% of ASP Isotopes shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Aemetis presently has a consensus target price of $12.95, suggesting a potential upside of 355.99%. ASP Isotopes has a consensus target price of $4.50, suggesting a potential downside of 20.49%. Given Aemetis' higher probable upside, equities research analysts plainly believe Aemetis is more favorable than ASP Isotopes.
Aemetis has a net margin of -33.21% compared to ASP Isotopes' net margin of -807.39%. Aemetis' return on equity of 0.00% beat ASP Isotopes' return on equity.
ASP Isotopes has lower revenue, but higher earnings than Aemetis. ASP Isotopes is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.
Summary
Aemetis and ASP Isotopes tied by winning 9 of the 18 factors compared between the two stocks.
Get Aemetis News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMTX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NASDAQ:AMTX) was last updated on 1/21/2025 by MarketBeat.com Staff
